These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23181351)

  • 1. All-trans-retinoic acid ameliorates experimental allergic encephalomyelitis by affecting dendritic cell and monocyte development.
    Zhan XX; Liu Y; Yang JF; Wang GY; Mu L; Zhang TS; Xie XL; Wang JH; Liu YM; Kong QF; Li HL; Sun B
    Immunology; 2013 Apr; 138(4):333-45. PubMed ID: 23181351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-Reactive Protein Suppresses the Th17 Response Indirectly by Attenuating the Antigen Presentation Ability of Monocyte Derived Dendritic Cells in Experimental Autoimmune Encephalomyelitis.
    Shen ZY; Zheng Y; Pecsok MK; Wang K; Li W; Gong MJ; Wu F; Zhang L
    Front Immunol; 2021; 12():589200. PubMed ID: 33841391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
    Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
    Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System.
    Chiou HC; Lin MW; Hsiao PJ; Chen CL; Chiao S; Lin TY; Chen YC; Wu DC; Lin MH
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
    Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
    J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-dihydroxyvitamin D
    Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
    Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitavastatin ameliorates autoimmune neuroinflammation by regulating the Treg/Th17 cell balance through inhibition of mevalonate metabolism.
    Prado DS; Damasceno LEA; Sonego AB; Rosa MH; Martins TV; Fonseca MDM; Cunha TM; Cunha FQ; Alves-Filho JC
    Int Immunopharmacol; 2021 Feb; 91():107278. PubMed ID: 33341737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
    Ge Z; Da Y; Xue Z; Zhang K; Zhuang H; Peng M; Li Y; Li W; Simard A; Hao J; Yao Z; Zhang R
    Exp Neurol; 2013 Mar; 241():56-66. PubMed ID: 23261766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of tumour necrosis factor-α in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology.
    Batoulis H; Recks MS; Holland FO; Thomalla F; Williams RO; Kuerten S
    Clin Exp Immunol; 2014 Jan; 175(1):41-8. PubMed ID: 24111507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.
    Li G; Yamasaki R; Fang M; Masaki K; Ochi H; Matsushita T; Kira JI
    Sci Rep; 2018 Jan; 8(1):1933. PubMed ID: 29386552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2.
    Ji Z; Fan Z; Zhang Y; Yu R; Yang H; Zhou C; Luo J; Ke ZJ
    J Immunol; 2014 Sep; 193(5):2157-67. PubMed ID: 25063874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
    Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
    J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
    Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
    Wang D; Lu Z; Zhang H; Jin SF; Yang H; Li YM; Shi LY
    CNS Neurosci Ther; 2016 Jul; 22(7):558-67. PubMed ID: 27013083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemically stable analogue of resolvin D1 ameliorates experimental autoimmune encephalomyelitis by mediating the resolution of inflammation.
    Zhang Q; Zhang Y; Zou M; Wu H; Liu C; Mi Y; Zhu J; Wang Y; Jin T
    Int Immunopharmacol; 2024 Oct; 140():112740. PubMed ID: 39116500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
    Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
    Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
    Kong W; Li H; Tuma RF; Ganea D
    Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
    Shen R; Deng W; Li C; Zeng G
    Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.